The Canadian dollar rose to a near three-week high against its U.S. counterpart on Monday, as investors weighed the potential for Canada's economy to escape broad-based U.S. tariffs and a report ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Protecting and conserving our natural heritage, predicting weather and environmental conditions, preventing and managing pollution, promoting clean growth and a sustainable environment for present and ...

President Donald Trump doubled down this week on his plans for an across the board 25% tariff on goods imported from Canada ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...